Padeliporfin for carcinoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 5 registered trials.

Why this status

  1. 30 Jun 2008: Trial registered, NCT00707356
  2. 27 Jul 2009: Trial registered, NCT00946881
  3. 11 Sep 2009: Trial registered, NCT00975429
  4. 11 Jun 2013: Trial registered, NCT01875393

The trials

NCT00707356: Study of WST11 in Patients With Localized Prostate Cancer

State
Completed
Phase
Phase 2
People
42 taking part
Started
Sep 2008
Primary completion
Jan 2011
Arms
WST11(TOOKAD® Soluble)
Results
None posted
  1. 30 Jun 2008: Trial registered

NCT00946881: Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

State
Completed
Phase
Phase 1 and Phase 2
People
30 taking part
Started
Jul 2009
Primary completion
Jul 2012
Arms
WST11 (TOOKAD® Soluble)
Results
Posted on the registry
  1. 27 Jul 2009: Trial registered
  2. 6 Nov 2017: Trial results posted

NCT00975429: Study Using WST11 in Patients With Localized Prostate Cancer

State
Completed
Phase
Phase 2
People
86 taking part
Started
Sep 2009
Primary completion
Dec 2011
Arms
WST11 - 4mg (TOOKAD® Soluble), WST11 - 6mg
Results
None posted
  1. 11 Sep 2009: Trial registered

NCT01875393: Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer

State
Completed
Phase
Phase 3
People
81 taking part
Started
May 2013
Primary completion
Dec 2014
Arms
TOOKAD® Soluble
Results
None posted
  1. 11 Jun 2013: Trial registered

NCT04225299: Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

State
Withdrawn before it started
Phase
Phase 3
People
0 taking part
Started
31 Mar 2020
Primary completion
31 Mar 2030
Arms
TOOKAD®
Results
None posted
  1. 13 Jan 2020: Trial registered
  2. 13 Nov 2020: Trial withdrawn

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as TOOKAD Soluble 4 mg/kg, Tookad®, TOOKAD® Soluble, WST 11 -mediated -VTP.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.